Vittoria Pinto

Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case

Giuliano Bensi, Marirosa Mora, Giovanna Tuscano et al. · Molecular & Cellular Proteomics · 2012 · 136 citations · Full text

Life Sciences, Immunology, Microbiology +17

Sequence Variation in Group A<i>Streptococcus</i>Pili and Association of Pilus Backbone Types with Lancefield T Serotypes

Fabiana Falugi, Chiara Zingaretti, Vittoria Pinto et al. · The Journal of Infectious Diseases · 2008 · 128 citations

Life Sciences, Immunology, Microbiology +12

Acidic pH Strongly Enhances <i>In Vitro</i> Biofilm Formation by a Subset of Hypervirulent ST-17 Streptococcus agalactiae Strains

Nunzia D’Urzo, Manuele Martinelli, Alfredo Pezzicoli et al. · Applied and Environmental Microbiology · 2014 · 94 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +16

Evaluation of a Group A Streptococcus synthetic oligosaccharide as vaccine candidate

Anna Kabanova, Immaculada Margarit, Francesco Berti et al. · Vaccine · 2010 · 94 citations

Veterinary Medicine, Immunology, Microbiology +14

Phosphorylation of the Synthetic Hexasaccharide Repeating Unit Is Essential for the Induction of Antibodies to <i>Clostridium difficile</i> PSII Cell Wall Polysaccharide

Roberto Adamo, Maria Rosaria Romano, Francesco Berti et al. · ACS Chemical Biology · 2012 · 85 citations

Veterinary Medicine, Immunology, Infectious Diseases +17